Other Helicobacters and the gastric microbiome

Helicobacter. 2018 Sep:23 Suppl 1:e12521. doi: 10.1111/hel.12521.

Abstract

The current article is a review of the most important, accessible, and relevant literature published between April 2017 and March 2018 on other Helicobacters and the gastric microbiome. The first part of the review focuses on literature describing non-Helicobacter pylori-Helicobacter (NHPH) infections in humans and animals whilst the subsequent section focuses specifically on the human gastric microbiome. Novel diagnostic methods as well as new NHPHs species have been identified in recent studies. Furthermore, our knowledge about the pathogenesis of NHPH infections has been further enhanced by important fundamental studies in cell lines and animal models. Over the last year, additional insights over the prevalence and potential prevention strategies of NHPHs have also been reported. With regard to understanding the gastric microbiome, new information detailing the structure of the gastric microbiota at different stages of H. pylori infection, within different patient geographical locations, was documented. There was also a study detailing the impact of proton-pump inhibitor usage and the effect on the gastric microbiome. Newer analysis approaches including defining the active microbiome through analysis of RNA rather than DNA-based sequencing were also published allowing the first assessments of the functional capabilities of the gastric microbiome.

Keywords: H. pylori; metatranscriptomics; microbiome; non-Helicobacter pylori Helicobacters; pediatrics.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / urine
  • Gastric Mucosa / microbiology
  • Gastrointestinal Microbiome / physiology*
  • Helicobacter / pathogenicity*
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / microbiology
  • Helicobacter Infections / prevention & control
  • Helicobacter pylori / pathogenicity
  • Humans
  • Proton Pump Inhibitors / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Proton Pump Inhibitors